• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Dolby Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition

    5/1/25 4:15:23 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous
    Get the next $DLB alert in real time by email
    8-K
    false 0001308547 0001308547 2025-05-01 2025-05-01
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported):

    May 1, 2025

     

     

    DOLBY LABORATORIES, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-32431   90-0199783

    (State or other jurisdiction of

    incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

    1275 Market Street

    San Francisco, CA 94103-1410

    (Address of principal executive offices) (Zip Code)

    (415) 558-0200

    (Registrant’s telephone number, including area code)

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange
    on which registered

    Class A common stock, $0.001 par value   DLB   The New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Section 2 – Financial Information

     

    ITEM 2.02

    Results of Operations and Financial Condition.

    The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

    On May 1, 2025, Dolby Laboratories, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended March 28, 2025. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

    Section 8 – Other Events

     

    ITEM 8.01

    Other Events

    Declaration of Dividend

    On May 1, 2025, the Company announced a cash dividend of $0.33 per share of Class A and Class B Common Stock, payable on May 21, 2025 to stockholders of record as of the close of business on May 13, 2025.

    Disclosure Channels to Disseminate Information

    The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.

    Section 9 – Financial Statements and Exhibits

     

    ITEM 9.01

    Financial Statements and Exhibits.

    (d) Exhibits.

     

    Exhibit
    No.

      

    Description

    99.1    Press Release of Dolby Laboratories, Inc. dated May 1, 2025
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      DOLBY LABORATORIES, INC.
    By:  

    /s/ Robert Park

      Robert Park
      Senior Vice President and Chief Financial Officer (Principal Financial Officer)

    Date: May 1, 2025

    Get the next $DLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DLB

    DatePrice TargetRatingAnalyst
    6/3/2024$100.00Mkt Perform → Outperform
    Barrington Research
    11/18/2022Outperform → Mkt Perform
    Barrington Research
    5/24/2022$90.00Buy
    Rosenblatt
    8/2/2021$115.00Mkt Perform → Outperform
    Barrington Research
    More analyst ratings

    $DLB
    Financials

    Live finance-specific insights

    See more
    • Dolby Laboratories Reports Second Quarter 2025 Financial Results

      SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2025. "We had a strong second quarter with continued momentum across our end markets, especially in Auto and Mobile," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While there is economic uncertainty, we are well positioned to operate across a range of scenarios. We are in a strong financial position, we continue to see strong engagement from our ecosystem, and we remain focused on driving long-term growth.

      5/1/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2025 Financial Results

      SAN FRANCISCO, April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2025 after the close of regular trading on Thursday, May 1, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 1, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-21

      4/8/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Reports First Quarter 2025 Financial Results

      SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. "We are off to a strong start for FY25," said Kevin Yeaman, President and CEO, Dolby Laboratories. "In Q1, Dolby Atmos and Dolby Vision momentum continued across device categories. At CES, many of our device partners announced a wide range of Dolby enabled products, and customers experienced the first Dolby Vision enabled car with Li Auto." First Quarter Fiscal 2025 Financial Highlights Total revenue was $357 mil

      1/29/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Dolby Laboratories Reports Second Quarter 2025 Financial Results

      SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2025. "We had a strong second quarter with continued momentum across our end markets, especially in Auto and Mobile," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While there is economic uncertainty, we are well positioned to operate across a range of scenarios. We are in a strong financial position, we continue to see strong engagement from our ecosystem, and we remain focused on driving long-term growth.

      5/1/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2025 Financial Results

      SAN FRANCISCO, April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2025 after the close of regular trading on Thursday, May 1, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 1, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-21

      4/8/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby and AMC Entertainment announce major expansion of Dolby Cinema at AMC in the US, with 40 additional auditoriums to be added by the end of 2027

      AMC has also selected Dolby Vision as its HDR offering of choice SAN FRANCISCO and LEAWOOD, Kan., March 31, 2025 /PRNewswire/ --  Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, and AMC Entertainment (NYSE:AMC), the largest theatrical exhibitor in the United States and in the world, today announced a significant expansion of their partnership, following a decade of success and guest popularity of the Dolby Cinema at AMC experience. Beginning this year, AMC and Dolby will add an additional 40 Dolby Cinema at AMC locations in the United States through the end of 2027.

      3/31/25 8:30:00 AM ET
      $AMC
      $DLB
      Movies/Entertainment
      Consumer Discretionary
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, Entertainment Couling John D sold $50,652 worth of shares (675 units at $75.04), decreasing direct ownership by 0.55% to 121,151 units (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      5/7/25 4:47:24 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SEC Form 4 filed by President and CEO Yeaman Kevin J

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      2/28/25 4:04:04 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SVP, Chief Marketing Officer Pendleton Todd exercised 7,286 shares at a strike of $71.07 and sold $1,517,668 worth of shares (18,121 units at $83.75), decreasing direct ownership by 23% to 37,290 units (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      2/21/25 5:17:52 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Leadership Updates

    Live Leadership Updates

    See more
    • OpenSesame Appoints Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors

      OpenSesame today announced it has appointed Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors. Dr. Elkeles is a highly regarded Chief Human Resources Officer and thought leader, advising globally on Talent, Learning, Human Resources, and Organization Development. Ms. Rollins has served hundreds of companies during her career at Deloitte, where she held various leadership positions in their U.S. Technology, Media, and Telecommunications practice, Audit Innovation and Transformation, and Diversity and Inclusion initiatives. Both executives bring decades of experience in technology, talent, finance, and governance to OpenSesame. Dr. Elkeles has spent 30 years in the human capit

      8/10/22 9:00:00 AM ET
      $DLB
      $GPX
      $SNCE
      $XMTR
      Multi-Sector Companies
      Miscellaneous
      Other Consumer Services
      Consumer Services
    • Dolby Laboratories Announces Dr. Shriram Revankar as SVP Advanced Technology Group

      SAN FRANCISCO, May 03, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, today announced the appointment of Dr. Shriram Revankar, a technologist and industry leader who has cultivated teams across multiple disciplines to deliver high impact technologies and world-class research, as its Senior Vice President Advanced Technology Group. Shriram will lead Dolby's global Advanced Technology Group building on the company's decades of innovation. Most recently, as Vice President and Fellow at Adobe, Shriram founded several of Adobe's global research labs, including the Big-Data Experience Lab and the Document Intelligence Lab. Through

      5/3/22 12:00:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Appoints Tony Prophet to its Board of Directors

      SAN FRANCISCO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) announced today the appointment of Tony Prophet to its Board of Directors, effective December 6, 2021. Over the course of many years, Tony has established himself as a technology industry leader who has helped guide companies across multiple disciplines. Most recently, Tony served as the Chief Equality and Recruiting Officer at Salesforce, co-chairing the Salesforce Racial Equality and Justice Task Force, created to help drive systemic change in the workplace and community. He was also a co-founder of the company's Ethical and Humane Use of technology initiative. During his time with Microsoft, Tony serve

      12/8/21 8:30:00 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $DLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $DLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $DLB
    SEC Filings

    See more
    • President and CEO Yeaman Kevin J bought $200 worth of shares (3 units at $78.15) (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      6/25/24 9:28:41 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Labs upgraded by Barrington Research with a new price target

      Barrington Research upgraded Dolby Labs from Mkt Perform to Outperform and set a new price target of $100.00

      6/3/24 9:17:02 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Labs downgraded by Barrington Research

      Barrington Research downgraded Dolby Labs from Outperform to Mkt Perform

      11/18/22 9:17:35 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Rosenblatt initiated coverage on Dolby Labs with a new price target

      Rosenblatt initiated coverage of Dolby Labs with a rating of Buy and set a new price target of $90.00

      5/24/22 7:27:36 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      11/13/24 4:05:17 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      9/10/24 4:39:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SEC Form SC 13G/A filed by Dolby Laboratories (Amendment)

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      2/13/24 5:02:35 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SEC Form 10-Q filed by Dolby Laboratories

      10-Q - Dolby Laboratories, Inc. (0001308547) (Filer)

      5/1/25 4:52:52 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition

      8-K - Dolby Laboratories, Inc. (0001308547) (Filer)

      5/1/25 4:15:23 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form SCHEDULE 13G/A filed by Dolby Laboratories

      SCHEDULE 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      4/30/25 10:55:37 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous